Home Halogens 4,5,6,7-Tetrabromobenzimidazole

4,5,6,7-Tetrabromobenzimidazole

CAS No.:
577779-57-8
Catalog Number:
AG00EBMN
Molecular Formula:
C7H2Br4N2
Molecular Weight:
433.7202
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
95%
In Stock USA
United States
$756
- +
250mg
95%
In Stock USA
United States
$1323
- +
1g
95%
In Stock USA
United States
$2646
- +
Product Description
Catalog Number:
AG00EBMN
Chemical Name:
4,5,6,7-Tetrabromobenzimidazole
CAS Number:
577779-57-8
Molecular Formula:
C7H2Br4N2
Molecular Weight:
433.7202
MDL Number:
MFCD04116202
IUPAC Name:
4,5,6,7-tetrabromo-1H-benzimidazole
InChI:
InChI=1S/C7H2Br4N2/c8-2-3(9)5(11)7-6(4(2)10)12-1-13-7/h1H,(H,12,13)
InChI Key:
LOEIRDBRYBHAJB-UHFFFAOYSA-N
SMILES:
Brc1c(Br)c(Br)c2c(c1Br)[nH]cn2
Properties
Complexity:
203  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
433.691g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
433.723g/mol
Monoisotopic Mass:
429.695g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
28.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.3  
Literature
Title Journal
A subnanomolar fluorescent probe for protein kinase CK2 interaction studies. Organic & biomolecular chemistry 20121121
Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro. Bioorganic & medicinal chemistry 20120715
CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. European journal of medicinal chemistry 20120101
HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Scientific reports 20120101
GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis. Nature chemical biology 20111201
Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2. Journal of proteome research 20111104
Design and synthesis of CK2 inhibitors. Molecular and cellular biochemistry 20111001
Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension. The Journal of neuroscience : the official journal of the Society for Neuroscience 20110601
Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors. Neuron 20100923
Genome-wide screen in Saccharomyces cerevisiae identifies vacuolar protein sorting, autophagy, biosynthetic, and tRNA methylation genes involved in life span regulation. PLoS genetics 20100701
Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro. Cell and tissue research 20100501
Dynamic regulation of a metabolic multi-enzyme complex by protein kinase CK2. The Journal of biological chemistry 20100409
Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes. BMC molecular biology 20100101
Synthesis and proapoptotic properties of new casein kinase II inhibitors. Acta poloniae pharmaceutica 20100101
Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells. International journal of oncology 20091101
Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2. Bioorganic & medicinal chemistry 20091015
Exploring the binding of inhibitors derived from tetrabromobenzimidazole to the CK2 protein using a QM/MM-PB/SA approach. Journal of chemical information and modeling 20090401
Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2. Bioorganic & medicinal chemistry 20090215
The selectivity of inhibitors of protein kinase CK2: an update. The Biochemical journal 20081101
New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole. Molecular and cellular biochemistry 20080901
Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO reports 20080801
An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Molecular & cellular proteomics : MCP 20080601
Ecto-phosphorylation of CD98 regulates cell-cell interactions. PloS one 20080101
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules. Chembiochem : a European journal of chemical biology 20071015
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2. Leukemia 20070101
Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2. Biochimica et biophysica acta 20051230
Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole. Chemistry & biology 20051101
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. Journal of medicinal chemistry 20041202
TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications. Biochemical and biophysical research communications 20031219
Polyhalogenobenzimidazoles: synthesis and their inhibitory activity against casein kinases. Bioorganic & medicinal chemistry 20030901
Alternative binding modes of an inhibitor to two different kinases. European journal of biochemistry 20030801
Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. Biochemical and biophysical research communications 20030620
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Properties